Cargando…
All‐trans retinoic acid reverses epithelial‐mesenchymal transition in paclitaxel‐resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions
Paclitaxel is a widely used chemotherapy drug, but development of resistance leads to treatment failure. Tumor cells that are treated with a sublethal dose of paclitaxel for a long period of time show the epithelial‐mesenchymal transition (EMT) phenotype, which leads to metastasis and resistance. Al...
Autores principales: | Shi, Guiling, Zheng, Xiaoli, Wu, Xiaojing, Wang, Siqi, Wang, Yijia, Xing, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317959/ https://www.ncbi.nlm.nih.gov/pubmed/30375704 http://dx.doi.org/10.1111/cas.13855 |
Ejemplares similares
-
All-trans retinoic acid restores gap junctional intercellular communication
between oral cancer cells with upregulation of Cx32 and Cx43 expressions in vitro
por: Wang, Juan, et al.
Publicado: (2013) -
Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition
por: YANG, YAN, et al.
Publicado: (2014) -
All-trans retinoic acid upregulates VEGF expression in glioma cells in vitro
por: Liang, Chen, et al.
Publicado: (2013) -
Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid
por: Yao, Jing, et al.
Publicado: (2014) -
pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-trans-retinoic acid and paclitaxel for cancer combination chemotherapy
por: Zhang, Yanqiu, et al.
Publicado: (2018)